1991
DOI: 10.1111/j.1744-313x.1991.tb00005.x
|View full text |Cite
|
Sign up to set email alerts
|

Hla‐dr, Do and Dp Typing Using PCR Amplification and Immobilized Probes

Abstract: A simple, rapid, and precise method of typing HLA class II polymorphism would be valuable in the areas of disease susceptibility, tissue transplantation, individual identification and anthropological genetics. Here we describe a method of analysing class II sequence polymorphism based on polymerase chain reaction (PCR) amplification and hybridization with oligonucleotide probes. One valuable property of sequence-based HLA typing strategies, like oligonucleotide probe hybridization, is that they reveal how and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
90
0
5

Year Published

1993
1993
2009
2009

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 188 publications
(95 citation statements)
references
References 27 publications
0
90
0
5
Order By: Relevance
“…Broad-level HLA-DRB1 typing and high-resolution DRB1‫40ء‬ typing were accomplished by initial polymerase chain reaction (PCR) amplification of groups of alleles (all DRB1 alleles for broad-level typing, and group-specific amplification for DRB1‫40ء‬ alleles) using biotinylated PCR primers, followed by hybridization to immobilized sequence-specific oligonucleotide probes in a linear array format. Positive hybridization reactions were detected using a streptavidinhorseradish peroxidase conjugate and a soluble colorless substrate, 3,3Ј,5,5Ј-tetramethylbenzidine (15). A computer algorithm based on the sequence-specific oligonucleotide probe hybridization pattern and the Anthony Nolan 1999 HLA sequence database (available at the World Wide Web site http://www.ebi.ac.uk/imgt/hla/nomen.html) were used to assign genotypes to each sample.…”
Section: Methodsmentioning
confidence: 99%
“…Broad-level HLA-DRB1 typing and high-resolution DRB1‫40ء‬ typing were accomplished by initial polymerase chain reaction (PCR) amplification of groups of alleles (all DRB1 alleles for broad-level typing, and group-specific amplification for DRB1‫40ء‬ alleles) using biotinylated PCR primers, followed by hybridization to immobilized sequence-specific oligonucleotide probes in a linear array format. Positive hybridization reactions were detected using a streptavidinhorseradish peroxidase conjugate and a soluble colorless substrate, 3,3Ј,5,5Ј-tetramethylbenzidine (15). A computer algorithm based on the sequence-specific oligonucleotide probe hybridization pattern and the Anthony Nolan 1999 HLA sequence database (available at the World Wide Web site http://www.ebi.ac.uk/imgt/hla/nomen.html) were used to assign genotypes to each sample.…”
Section: Methodsmentioning
confidence: 99%
“…Positive hybridization reactions were detected using a streptavidin-horseradish peroxidase conjugate and a soluble colorless substrate TMB (3,3 0 ,5,5 0 -tetramethylbenzidine). 59 A computer algorithm based on the sequence specific oligonucleotide probe hybridization pattern and the Anthony Nolan 1999 HLA sequence database (http://www.ebi.ac.uk/imgt/hla/) was used to assign genotypes. The following alleles detected were classified as 'SE' positive: DRB1*0101, 0102, 0104, 0105, 0401, 0404, 0405, 0408, 0409, 1001, 1402 and 1406.…”
Section: Study Populationmentioning
confidence: 99%
“…Também se confi rmou a origem fetal das células mesenquimais coletadas do líquido amniótico e cultivadas in vitro por meio da tipagem molecular dos antígenos leucocitários humanos. (ERLICH, et al, 1991 A utilização das CTM no reparo tecidual é estudada há tempos (BRUDER, et al, 1993), porém, o potencial dessas células proporciona muitas outras aplicações experimentais. Seu potencial de diferenciação em diversos tecidos, suas propriedades imunossupressoras e a relativa facilidade de manuseio in vitro fazem das CTM uma ferramenta importante para, entre outras coisas, a engenharia tecidual, tratamento de doenças degenerativas e estudo de novos fármacos.…”
Section: Introductionunclassified